Pulse Biosciences (PLSE) Cash & Equivalents (2020 - 2025)
Historic Cash & Equivalents for Pulse Biosciences (PLSE) over the last 6 years, with Q3 2025 value amounting to $95.2 million.
- Pulse Biosciences' Cash & Equivalents rose 2047.37% to $95.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $95.2 million, marking a year-over-year increase of 2047.37%. This contributed to the annual value of $118.0 million for FY2024, which is 16606.11% up from last year.
- Per Pulse Biosciences' latest filing, its Cash & Equivalents stood at $95.2 million for Q3 2025, which was up 2047.37% from $106.3 million recorded in Q2 2025.
- Pulse Biosciences' 5-year Cash & Equivalents high stood at $119.3 million for Q1 2025, and its period low was $12.7 million during Q1 2022.
- In the last 5 years, Pulse Biosciences' Cash & Equivalents had a median value of $54.1 million in 2023 and averaged $59.9 million.
- In the last 5 years, Pulse Biosciences' Cash & Equivalents skyrocketed by 66148.27% in 2021 and then plummeted by 7883.21% in 2022.
- Pulse Biosciences' Cash & Equivalents (Quarter) stood at $44.4 million in 2021, then skyrocketed by 37.81% to $61.1 million in 2022, then fell by 27.44% to $44.4 million in 2023, then soared by 166.06% to $118.0 million in 2024, then fell by 19.34% to $95.2 million in 2025.
- Its Cash & Equivalents stands at $95.2 million for Q3 2025, versus $106.3 million for Q2 2025 and $119.3 million for Q1 2025.